Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)
Paul L. Wood(Lincoln Memorial University), Giovanni Zuliani(University of Ferrara), Carlo Cervellati(University of Ferrara), Giovanni Battista Vigna(University of Ferrara), Patrick Herling(Lincoln Memorial University), Victoria A. Locke(Lincoln Memorial University), Stefano Volpato(University of Ferrara), Angelina Passaro(University of Ferrara), Giuseppe Valacchi(University of Ferrara)
Cited by 61
Related Papers
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
|BMC Medicine|2016|904
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
|The Lancet|2012|739
Handgrip Strength and Cause‐Specific and Total Mortality in Older Disabled Women: Exploring the Mechanism
|Journal of the American Geriatrics Society|2003|664
Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels
|Journal of the American Geriatrics Society|2002|619
Predictive Value of the Short Physical Performance Battery Following Hospitalization in Older Patients
|The Journals of Gerontology Series A|2010|465